These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38552412)

  • 1. 271st ENMC international workshop: Towards a unifying effort to fight Kennedy's disease. 20-22 October 2023, Hoofddorp, Netherlands.
    Pennuto M; Pradat PF; Sorarù G; Greensmith L;
    Neuromuscul Disord; 2024 May; 38():8-19. PubMed ID: 38552412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 241st ENMC international workshop: Towards a European unifying lab for Kennedy's disease. 15-17th February, 2019 Hoofddorp, The Netherlands.
    Greensmith L; Pradat PF; Sorarù G; Pennuto M;
    Neuromuscul Disord; 2019 Sep; 29(9):716-724. PubMed ID: 31488386
    [No Abstract]   [Full Text] [Related]  

  • 3. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
    Breza M; Koutsis G
    J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.
    Arnold FJ; Merry DE
    Neurotherapeutics; 2019 Oct; 16(4):928-947. PubMed ID: 31686397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy.
    Pennuto M; Gozes I
    J Mol Neurosci; 2016 Mar; 58(3):313-6. PubMed ID: 26875173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.
    Pradat PF; Bernard E; Corcia P; Couratier P; Jublanc C; Querin G; Morélot Panzini C; Salachas F; Vial C; Wahbi K; Bede P; Desnuelle C;
    Orphanet J Rare Dis; 2020 Apr; 15(1):90. PubMed ID: 32276665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of spinal bulbar muscular atrophy (Kennedy's disease) and avenues for treatment.
    Grunseich C; Fischbeck KH
    Curr Opin Neurol; 2020 Oct; 33(5):629-634. PubMed ID: 32773451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked spinal and bulbar muscular atrophy (Kennedy's disease): the first case described in the Brazilian Amazon.
    Alves CN; Braga TKK; Somensi DN; Nascimento BSVD; Lima JAS; Fujihara S
    Einstein (Sao Paulo); 2018 Jun; 16(2):eRC4011. PubMed ID: 29898093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kennedy disease (X-linked recessive bulbospinal neuronopathy): A comprehensive review from pathophysiology to therapy.
    Querin G; Sorarù G; Pradat PF
    Rev Neurol (Paris); 2017 May; 173(5):326-337. PubMed ID: 28473226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
    Pennuto M; Rinaldi C
    Mol Cell Endocrinol; 2018 Apr; 465():113-121. PubMed ID: 28688959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of UBA1 as the causative gene of an X-linked non-Kennedy spinal-bulbar muscular atrophy.
    Khani M; Nafissi S; Shamshiri H; Moazzeni H; Taheri H; Sadeghi M; Salehi N; Chitsazian F; Elahi E
    Eur J Neurol; 2022 Dec; 29(12):3556-3563. PubMed ID: 35996994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrinal description of two Chinese Kennedy's disease pedigrees.
    Li F; Aji G; Leng F; Chen JC; Luo Y; Zhang J; Hu K; Cheng ZY; Xu X; Lu ZQ
    J Clin Neurosci; 2018 Jan; 47():245-248. PubMed ID: 29102238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations and AR gene mutations in Kennedy's disease.
    Liu X; Zhu M; Li X; Tang J
    Funct Integr Genomics; 2019 May; 19(3):533-539. PubMed ID: 30612224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle.
    Marchioretti C; Andreotti R; Zuccaro E; Lieberman AP; Basso M; Pennuto M
    Curr Opin Pharmacol; 2023 Aug; 71():102394. PubMed ID: 37463556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New routes to therapy for spinal and bulbar muscular atrophy.
    Rocchi A; Pennuto M
    J Mol Neurosci; 2013 Jul; 50(3):514-23. PubMed ID: 23420040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease).
    Finsterer J; Soraru G
    J Mol Neurosci; 2016 Mar; 58(3):321-9. PubMed ID: 26482145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Trials in Spinal and Bulbar Muscular Atrophy-Past, Present, and Future.
    Weydt P; Sagnelli A; Rosenbohm A; Fratta P; Pradat PF; Ludolph AC; Pareyson D
    J Mol Neurosci; 2016 Mar; 58(3):379-87. PubMed ID: 26572537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kennedy's disease presented with mastication fatigue combined with positive titin antibody: a case report.
    Ji G; Huang R; Zhou X; Cao C; Wu Q; Li Z; Dong H; Song X; Liu Y
    BMC Neurol; 2022 Nov; 22(1):425. PubMed ID: 36376797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of androgen receptor polyQ chain elongation in Kennedy's disease and use of natural osmolytes as potential therapeutic targets.
    Kumar R
    IUBMB Life; 2012 Nov; 64(11):879-84. PubMed ID: 23024039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease.
    Manzano R; Sorarú G; Grunseich C; Fratta P; Zuccaro E; Pennuto M; Rinaldi C
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):808-812. PubMed ID: 29353237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.